Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1526-632X